Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Neuropathic Pain Pain Pathophysiology • Nociceptive pain • Neuropathic pain Nociceptive Pain • Sensitization and activation of “healthy” nociceptor endings and recruitment of “silent” nociceptors • “Soup” of inflammatory algogenic agents, such as protons, prostaglandins, bradykinin, serotonin, adenosine, histamine, cytokines Mechanisms of Neuropathic Pain • Noninflammatory states • Inflammatory states Pathophysiology of Neuropathic Pain • Ectopic activity in the peripheral pathways, including axons and DRG • CNS mechanisms Neuropathic Pain: Central Mechanisms Peripheral neuropathic events can be complicated by temporary or long-term CNS changes, such as central sensitization and then reorganization of the pain pathways at the dorsal horn level Neuropathic Pain and SMP • Some neuropathic pains are sustained, at least in • • part, by sympathetic efferent activity – SMP Expression of alpha-adrenergic receptors on injured C-fibers may be a relevant mechanism of SMP, but others are possible Clinical findings consistent with CRPS signal an increased likelihood of SMP Nociceptive Pain Neuropathic Pain PNS peripheral nervous system CNS central nervous system Peripheral sensitization “Healthy” Abnormal nociceptors nociceptors PNS Central CNS Normal transmission sensitization Central reorganization Physiologic state Pappagallo M. 2001. Pathologic state Neuropathic Pain • Diverse syndromes with uncertain classification • Mononeuropathies and polyneuropathies • CRPS • Deafferentation syndromes, including central pain Painful Mononeuropathies and Polyneuropathies • • • • • • • • Diabetic neuropathies Entrapment neuropathies Shingles and postherpetic neuralgia Trigeminal and other CNS neuralgias HIV-related neuropathy Neuropathy due to malignant disease Neuropathy due to rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome Idiopathic distal small-fiber neuropathy Painful Mononeuropathies and Polyneuropathies • Neuropathies due to toxins: arsenic, thallium, • • • • • alcohol, vincristine, cisplatinum, didioxynucleosides Amyloid polyneuropathy: primary and familial Neuropathies with monoclonal proteins Vasculitic neuropathy Neuropathy associated with Guillain-Barré syndrome Neuropathy associated with Fabry’s disease Neuropathic Pain: Clinical Assessment • A comprehensive diagnostic approach to patients affected by neuropathic pain – Medical history – Examinations: general, neurologic, regional – Diagnostic workup: imaging studies, laboratory tests, nerve/skin biopsies, electromyography/nerve-conduction velocity (EMG-NCV) studies, selected nerve blocks Medical History Ask patient about complaints suggestive of • Neurologic deficits: persistent numbness in a body area or limb-weakness, for example, tripping episodes, inability to open jars • Neurologic sensory dysfunction: touchevoked pain, intermittent abnormal sensations, spontaneous burning and shooting pains Neurologic and Regional Examinations In patients with neuropathic pain, examination should focus on the anatomic pattern and localization of the abnormal sensory symptoms and neurologic deficits Neuropathic Pain: Clinical Characteristics • Burning, shooting, electrical-quality pain • May be aching, throbbing, sharp • Neuropathic sensations: dysesthesias, paresthesias Neuropathic Sensations • Paresthesias: abnormal; spontaneous, intermittent, painless • Dysesthesias: abnormal; spontaneous or touch-evoked, unpleasant Neuropathic Pain: Evoked Dysesthesias • Allodynia: pain elicited by a nonnoxious stimulus (clothing, air movement, touch) – Mechanical (induced by light pressure) – Thermal (induced by a nonpainful cold or warm stimulus) • Hyperalgesia: exaggerated pain response to a • mildly noxious (mechanical or thermal) stimulus Hyperpathia: delayed and explosive pain response to a noxious stimulus Primary Hyperalgesia • Present in the primary zone, at the location of injury • Characterized by pinprick hyperalgesia + warm and heat hyperalgesia + static mechanical allodynia (tenderness) • Indicative of PNS sensitization Secondary Hyperalgesia • Present in the zone surrounding an injury • Characterized by dynamic mechanical allodynia + cold hyperalgesia • Indicative of CNS sensitization Diagnostic Workup: Lab Tests • Complete blood cell count with differential, • • • • erythrocyte sedimentation rate, chemistry profile Thyroid-function tests, vitamin B12 and folate, fasting blood sugar, and glycosylated hemoglobin Serum protein electrophoresis with immunofixation Lyme titers, hepatitis B and C, HIV screening Antinuclear antibodies, rheumatoid factor, Sjögren’s titers (SS-A, SS-B), antineutrophil cytoplasmic antibody Diagnostic Workup: Lab Tests • • • • Cryoglobulins Antisulfatide antibody titers, anti-HU titers Heavy metals serum and urine screens Cerebrospinal fluid study for demyelinating diseases and meningeal carcinomatosis Diagnostic Workup: Electrophysiologic Studies EMG-NCV and QST • To localize pain-generator/nerve or root lesion • To rule out – Axonal vs focal segmental demyelination – Underlying small-fiber or mixed polyneuropathy Biopsies • Nerve (eg, sural nerve): to diagnose vasculitis, amyloidosis, sarcoidosis, etc. • Skin: to evaluate density of unmyelinated fibers within dermis and epidermis Neuropathic Pain: Management • Pharmacotherapy – Nonopioid – Opioid – Adjuvant analgesics • Interventional – Neural blockade (eg, sympathetic nerve blocks) – Neurostimulatory techniques (eg, spinal cord stimulation) – Intraspinal infusion Neuropathic Pain: Pharmacologic Therapies • Gabapentin, carbamazepine, lamotrigine, • • • • and newer AEDs Antidepressants Opioid analgesics Lidocaine (transdermal, intravenous [IV]), mexiletine Alpha-2 adrenergic agonists Neuropathic Pain: Management • Rehabilitative approaches • Psychologic interventions Conclusions • More effective medical therapies for neuropathic pain are becoming available and physicians should use them to limit unnecessary suffering, with the ultimate goal of significantly improving patients’ quality of life